Featured Post

What to Know About COVID Pneumonia

Image
tb gold test :: Article Creator Scientists Develop A TB Test & Find A Genetic Vulnerability In Resistant Strains A rapid diagnostic test for tuberculosis (TB) has been approved for the first time by the World Health Organization (WHO). The assay can identify the tuberculosis-causing pathogen Mycobacterium tuberculosis in sputum samples within a few hours. Tuberculosis is a primary cause of death by infectious disease worldwide. The disease is estimated to kill over one million people every year, and is a huge socio-economic burden, particularly in low- and middle-income countries. "High-quality diagnostic tests are the cornerstone of effective TB care and prevention," said Dr. Rogerio Gaspar, WHO Director for Regulation and Prequalification. "Prequalification paves the way for equitable access to cutting-edge technologies, empowering countries to address the dual burden of TB and drug-resistant TB."  M. Tuberculosis c...

Growing Number of Patients and Improving Methods to Drive Perianal Infection Treatment Market, Finds Fact.MR - BioSpace

Growing Number of Patients and Improving Methods to Drive Perianal Infection Treatment Market, Finds Fact.MR - BioSpace


Growing Number of Patients and Improving Methods to Drive Perianal Infection Treatment Market, Finds Fact.MR - BioSpace

Posted: 24 Jan 2021 10:02 PM PST

North America is likely to pose lucrative revenue growth opportunities for perianal infection treatment market on account of burgeoning healthcare expenditure by consumers and early adoption of the innovative and new technologies. Asia-Pacific perianal infection treatment market is likely to grow at an impressive pace on account of trending medical tourism, improving healthcare infrastructure and growing awareness regarding perianal infection treatment. However, dearth of awareness regarding perianal infection treatment coupled with inadequate medical infrastructure is expected to restrain the growth of Africa perianal infection treatment market. New product launches and technological advancements in perianal infection treatment will further stimulate the growth of perianal infection treatment market in the forthcoming years.

Request a Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=952

Increasing Pool Patient Is Key Market Driver

Perianal infections may be accompanied by inflammation of the vulva & vagina in girls or end of the penis in boys. Most children diagnosed with perianal infection have positive cultures for group A beta-hemolytic streptococcal infections (GABHS). Common treatment options include topical antifungal agents such as topical amoxicillin, mupirocin, or penicillin. In severe cases, oral antibiotics are recommended. Oral antibiotic treatment shows dramatic improvement within 24 hours. Prolonged antibiotic treatment for 7-14 days is prescribed to increase the cure rate. Other antibiotics prescribed for the treatment of perianal infection include erythromycin, azithromycin, and clarithromycin, among others. "However, in adults, perianal infections are not easily treated with oral antibiotics, and they require sufficiently long courses. According to a study conducted by The Association of Coloproctology of Great Britain and Ireland, only 42% adult patients with perianal infections were cured after the first course of antibiotics," finds Fact.MR In adults, additional anorectal or dermatological diseases may develop, which extend the course of treatment.

Increasing patient pool owing to higher incidence rates of anal fistula and the recurrence rate of the treated cases is significantly driving growth of perianal infection treatment market. In addition, growing incidences of anal fistula stimulating co-morbidities has led to more complicated anal fistula cases, thereby driving the demand for perianal infection treatment. Rising demand for effective and safe perianal infection treatment with assurance of no recurrence and lesser side-effects have been creating growth opportunities for manufacturers. This in turn will lead to development of advanced and new devices and drugs benefitting perianal infection treatment market.

Request the TOC at - https://www.factmr.com/report/952/perianal-infection-treatment-market

Lower Awareness about Treatment Methods May Deter Market Growth

Growing incidences and recurrence of perianal infection is the major factor expected to drive the growth of the perianal infection treatment market over the forecast period. Approximately 39% of patients show recurrence of perianal infections. "Recurrence may be caused due to poor compliance rates or incomplete treatment regimes. Incidences of additional anorectal diseases in adults such as haemorrhoids or damaged perianal skin is another factor driving the growth of the global perianal infection treatment market," notes Fact.MR However, lack of treatment adherence, low treatment seeking rates, misdiagnosis of a disease, etc., are the major factors deterring the growth of the global perianal infection treatment market.

The global market for perianal infection treatment is highly fragmented, with numerous regional players operating in it. Some of the market players identified in the global perianal infection treatment market are Baxter International Inc., Hospira Inc. (Pfizer Inc.), Sandoz (Novartis AG), Arbor Pharmaceuticals LLC, Abbott, Eli Lilly & Co. Ltd., Allergen Plc., Teva Pharmaceutical Industries Ltd., Cardinal Health Inc., and Abbvie Inc. among others.

Explore Fact.MR's Lucid Healthcare Coverage

Drug Discovery Services Market – Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services

Fluid Management Market – The rise in incidences of End Stage Renal Disease (ESRD) has pushed up demand for dialysis products, thus augmenting the global fluid management market. The market is poised to be leveraged moderately at a CAGR of 5.3% during the forecast period (2020-2025). 

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
U.S Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Website: https://www.factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Source: Fact.MR

Comments

Popular Posts

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University

Model Monday's: Diana Moldovan

“Live Coronavirus Map Used to Spread Malware - Krebs on Security” plus 1 more